Evaluation and Testing Services for Vaccines and Other Biologics for Infectious Diseases

The National Institutes of Health is forecasting a contract to procure evaluation and testing services for vaccines and other biologics targeting infectious diseases, with the North American Industry Classification System code 541714 indicating research and development in the physical, engineering, and life sciences. This initiative will support critical scientific efforts to assess the safety, efficacy, and performance of biological products designed to prevent or treat infectious agents, likely involving laboratory analysis, clinical trial support, and regulatory compliance testing. The contract is not currently open for bidding but is posted as a forecast to inform industry of upcoming procurement plans, with no set-aside provisions indicated at this time. Point of contact for program inquiries is Lisa Wei, reachable at lisa.wei@nih.gov, while Sharee Richardson serves as the Contracting Officer and can be contacted at sharee.richardson@nih.gov for procurement-related questions. The work is expected to be performed in support of NIH research objectives, though specific locations for performance have not been designated. Interested parties should monitor the official portal at https://osdbu.hhs.gov/industry/opportunity-forecast for future solicitation updates, as the forecast was published on May 25, 2026, and a formal request for proposals is anticipated in the coming months.